TrialJournal of the American Society of Nephrology : JASN2012
Rituximab in idiopathic membranous nephropathy.
Piero Ruggenenti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
158 papers cite itlatest 60 shown
this paperpooled ittrialcites it